AMAC Telephony Based Communication Services receives large scale award

American Medical Alert Corp. (NASDAQ: AMAC) a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced that its Telephony Based Communication Services ("TBCS") was awarded a three year, pharmaceutical brand support and clinical contact communications contract for an internationally recognized, top ten pharmaceutical manufacturer. This large scale award will entail end to end brand support communications for four brands. AMAC was chosen through a competitive process for its proven ability to exceed brand goals on inaugural, as well as current projects performed for this Fortune 500 Company. The award is expected to generate approximately three million dollars in revenue over the term of the contract.

Jack Rhian, AMAC's President and Chief Executive Officer explained, "This award confirms the core value proposition of AMAC's pharmaceutical support offerings. Our team's holistic approaches to service development, quality and customer satisfaction have been authenticated by this award as a replicable model of service delivery and revenue growth. We anticipate the trend towards increased utilization of pharmaceutical communications to further brand awareness and market penetration will continue and that AMAC's proprietary service model will be in demand by many other pharmaceutical brands seeking to achieve their objectives through AMAC's unique approach.

SOURCE American Medical Alert Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exploring AI's role in transforming healthcare diagnosis and treatment